Moderna Offered Children £1,500 to Enroll in COVID Booster Shot Trial
The Prescription Medicines Code of Practice Authority (PMCPA), an organization responsible for overseeing the marketing practices of pharmaceutical companies in the United Kingdom, criticized Moderna, Inc. for sending an unauthorized WhatsApp message that proposed a payment of £1,500 (about $2,000) to children for participating in a clinical trial for its COVID-19 booster shot.1 Complaint Filed […]
Food Allergy Diagnoses in England Have Doubled
Results from a new study published in The Lancet earlier this month indicate that there are more children and adults in England suffering with food allergies. The study, which was conducted by researchers at Imperial College in London, showed that the incidence of food allergies among adults and children doubled between 2008 and 2018.1 The […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]
More Parents in U.K. Refuse Childhood Vaccinations
In late 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that there had been a decline in state required vaccines from 95 percent to 93 percent among kindergarteners during the 2020-2021 school year compared to the 2019-2020 school year.1 2 Now, public health officials in the United Kingdom also are reporting lower […]
Moderna Stops mRNA COVID Biologics Plant Construction in Kenya
Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility in Kenya while it determines projected future demand for mRNA biologics in Africa. Company officials concluded that, since the end of the COVID pandemic, interest in COVID-19 biologics in Kenya and Africa has […]
